24 results
DEFA14A
EX-99.1
ALKS
Alkermes plc
11 Jan 22
Additional proxy soliciting materials
7:02am
in synaptic integrity, density and function PBMCs: Peripheral blood mononuclear cells; CSF: Cerebrospinal fluid; PET: Positron emission tomography; qEEG
8-K
EX-99.1
ALKS
Alkermes plc
11 Jan 22
Regulation FD Disclosure
7:00am
in synaptic integrity, density and function PBMCs: Peripheral blood mononuclear cells; CSF: Cerebrospinal fluid; PET: Positron emission tomography; qEEG
10-KT
vai84 hc7qlfsrzm
27 Feb 14
Annual report (with FYE transition)
12:00am
8-K
EX-10.1
l9zk cwkz
25 Sep 12
Alkermes PLC Closes Debt Refinancing, Lowering Interest Rate and Reducing Principal Amount
12:00am
10-K
8b16qe0 marque
18 May 12
Annual report
12:00am
424B3
cc2iej
8 Mar 12
Prospectus supplement
12:00am